We’ve recently updated our valuation analysis.

Thorne HealthTech Valuation

Is F7G undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for F7G?

Other financial metrics that can be useful for relative valuation.

F7G key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.2x
Enterprise Value/EBITDA67.5x
PEG Ratio1x

Price to Earnings Ratio vs Peers

How does F7G's PE Ratio compare to its peers?

F7G PE Ratio vs Peers
The above table shows the PE ratio for F7G vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average30.8x
BEI Beiersdorf
31x8.7%€22.9b
VICI Victoria Care Indonesia
29.1xn/aRp4.0t
LLQ Lalique Group
26.8x9.7%CHF239.6m
603059 Perfect Group
36.4xn/aCN¥1.8b
F7G Thorne HealthTech
79.6x76.4%€249.5m

Price-To-Earnings vs Peers: F7G is expensive based on its Price-To-Earnings Ratio (79.6x) compared to the peer average (30.8x).


Price to Earnings Ratio vs Industry

How does F7G's PE Ratio compare vs other companies in the European Personal Products Industry?

Price-To-Earnings vs Industry: F7G is expensive based on its Price-To-Earnings Ratio (79.6x) compared to the European Personal Products industry average (19.5x)


Price to Earnings Ratio vs Fair Ratio

What is F7G's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

F7G PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio79.6x
Fair PE Ratio39.3x

Price-To-Earnings vs Fair Ratio: F7G is expensive based on its Price-To-Earnings Ratio (79.6x) compared to the estimated Fair Price-To-Earnings Ratio (39.3x).


Share Price vs Fair Value

What is the Fair Price of F7G when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate F7G's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate F7G's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies